ArticleInvestigative ophthalmology & visual science2026
Optic Nerve Alterations Following Intravitreal Injection and Laser in Infants With Retinopathy of Prematurity.
Article in Investigative ophthalmology & visual science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: The purpose of this study was to compare the effects of intravitreal injection and laser treatment for retinopathy of prematurity (ROP) on the optic nerve in infants. Methods: This was a retrospective cohort study. The participants were 551 eyes of preterm infants from January 2022 to March 2025. The preterm infants enrolled in this study were divided into the ROP treatment group, the ROP group, and the healthy control group. The treatment group was further subdivided into the intravitreal injection group and the laser group. Results: The vertical cup-to-disc ratio of the optic nerve in retinal images was measured at 4-week intervals from 36 to 60 weeks postmenstrual age (PMA). From PMA 36 to 60 weeks, the cup-to-disc ratio demonstrated significantly greater growth in the ROP treatment group in comparison to the other two groups. Starting from 40 weeks PMA, a statistically significant elevation in the cup-to-disc ratio was observed in the intravitreal injection group compared with the laser group and the control group. Additionally, except for the 56- to 60-week PMA, the intravitreal injection group showed higher cup-to-disc ratio increases than the laser group. Conclusions: The present study found that treated ROP leads to a higher cup-to-disc ratio. Furthermore, intravitreal injections result in a greater increase in cup-to-disc ratio compared to laser treatment, with this effect persisting up to 60 weeks PMA.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.